Hematopoietic stem cell transplant with a carrier donor rescues CD40L deficiency
Year: 2026
Type: article
Study design: Case Report
Abstract: This study demonstrates successful hematopoietic stem cell transplant of CD40L deficiency using an asymptomatic carrier mother, leading to sustained 32% CD40L expression, normal recovery of T and B cell development and diversity, and expected growth and development 7.5 years post-transplant.
Source: Journal of Human Immunity
Institutions: University of Minnesota, Children's Minnesota, Mayo Clinic
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W7129218828
